Skip to main content
CCRN
NASDAQ Trade & Services

Cross Country Healthcare Announces Departure of CAO and CIO, Appoints Internal Successor as CAO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$9.85
Mkt Cap
$322.686M
52W Low
$7.43
52W High
$16.185
52W Position info
33% above low
Off High info
39% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CCRN sits 33% above its 52-week low of $7.43.

Summary

Cross Country Healthcare announced the departure of its Chief Accounting Officer and Chief Information Officer, simultaneously appointing an internal candidate as the new CAO.


Key Events · Executive and Board Changes · CCRN

  • Departure of Key Officers

    James V. Redd III ceased to serve as Senior Vice President and Chief Accounting Officer, and Phil Noe ceased to serve as Chief Information Officer, both effective March 10, 2026. The company explicitly stated these departures were not due to any disputes or disagreements regarding accounting practices or financial reporting.

  • Internal Appointment of New Chief Accounting Officer

    Marvin Veizaga, who has been with the company since 2015 and most recently served as Group Vice President, Corporate Controller, was appointed as the new Senior Vice President, Chief Accounting Officer, effective March 10, 2026.

  • New CAO Compensation Details

    In connection with his appointment, Mr. Veizaga's base salary will be $340,000, and he will be eligible for an annual short-term incentive bonus target of 50% of his base salary and an annual long-term incentive equity award target of 50% of his base salary.


Analysis · CCRN · Trade & Services

This filing details significant changes in Cross Country Healthcare's executive leadership, specifically the departure of its Chief Accounting Officer (CAO) and Chief Information Officer (CIO). While the company states these departures were not due to disputes over accounting practices or financial reporting, the change in the CAO role is notable, especially following the recent reports of substantial net losses and goodwill impairment in the company's Q4 and full-year 2025 financial results. The appointment of Marvin Veizaga, a long-term internal candidate, as the new CAO provides continuity and may help stabilize the financial reporting function during a challenging period for the company. Investors will likely monitor future financial disclosures for signs of stability under the new leadership.

At the time of this filing, CCRN was trading at $9.85 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $322.7M. The 52-week trading range was $7.43 to $16.19. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CCRN - Latest Insights

CCRN
Jul 06, 2026, 6:23 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $13.20
Real-time Price: $13.25 info
Change: +$0.050 (+0.38%) info
Market Cap: $428.061M info
CCRN
Jul 06, 2026, 6:19 AM EDT
Filing Type: 425
Importance Score:
8
Price at Filing: $13.20
Real-time Price: $13.25 info
Change: +$0.050 (+0.38%) info
Market Cap: $428.061M info
CCRN
Jul 06, 2026, 6:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.20
Real-time Price: $13.25 info
Change: +$0.050 (+0.38%) info
Market Cap: $428.061M info
CCRN
Jun 23, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $13.21
Real-time Price: $13.25 info
Change: +$0.040 (+0.30%) info
Market Cap: $428.061M info
CCRN
Jun 23, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.21
Real-time Price: $13.25 info
Change: +$0.040 (+0.30%) info
Market Cap: $428.061M info